[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342089-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-342089-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","risk-of-second-primary-cancers-in-nodal-non-hodgkin-lymphoma-patients-by-primary-lymph-node-location-cohort-study","Risk of second primary cancers in nodal non-Hodgkin lymphoma patients by primary lymph node location - Cohort study","","Non-Hodgkin lymphoma survivors face a substantial risk of developing second primary cancers, which can negatively affect long-term survival. This retrospective, population-based cohort study used U.S. Surveillance, Epidemiology, and End Results data from 2000–2021 to evaluate risk of second primary cancers by the site of the primary lymph node and by latency since the initial nodal NHL diagnosis. Among 54,012 patients, second primary cancer risk varied by lymph node location, with highest risks for thyroid cancer, acute myeloid leukemia, and Hodgkin lymphoma. Findings support tailored surveillance and prevention strategies, with further research needed to clarify underlying mechanisms.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/risk-of-second-primary-cancers-in-nodal-non-hodgkin-lymphoma-patients-by-primary-lymph-node-location-cohort-study/342089/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/risk-of-second-primary-cancers-in-nodal-non-hodgkin-lymphoma-patients-by-primary-lymph-node-location-cohort-study/342089.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study?","Question",{"text":63,"@type":64},"To determine how the primary lymph node location and the latency period after nodal non-Hodgkin lymphoma diagnosis influence the risk of second primary cancers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study conducted?",{"text":68,"@type":64},"It used a retrospective population-based cohort design with Surveillance, Epidemiology, and End Results data from 2000 to 2021, including nodal NHL patients as first primary cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"Which second primary cancers showed the highest risks?",{"text":72,"@type":64},"The highest risks were reported for thyroid cancer, acute myeloid leukemia, and Hodgkin lymphoma.",{"name":74,"@type":61,"acceptedAnswer":75},"Why do the results matter for patient care?",{"text":76,"@type":64},"The risk varies by lymph node site and latency, supporting the need for tailored surveillance strategies and preventive measures, along with further research into underlying mechanisms.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},342089,1790907304,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","’Cohort Study  \nRisk of second primary cancers in nodal nonHodgkin lymphoma patients by primary lymph node location: a retrospective cohort population-based study  \nAli Hemade, MDa,*, Souheil Hallit, PharmD, MSc, MPH, PhDb,c  \nBackground: Non-Hodgkin lymphoma (NHL) is a diverse group of blood cancers with increasing incidence and survival rates due to advancements in treatment and early detection. However, NHL survivors are at signiﬁcant risk of developing second primary cancers, which can adversely impact their long-term survival.  \nMethods: This retrospective population-based cohort study utilized data from the Surveillance, Epidemiology, and End Results database, covering 17 geographic areas in the United States from 2000 to 2021 . The authors included patients diagnosed with nodal NHL as a ﬁrst primary cancer and excluded those diagnosed at autopsy or via death certiﬁcate only. Standardized Incidence Ratios, Absolute Excess Risks, and Person-Years at Risk were calculated to evaluate the risk of developing SPCs according to the primary lymph node site and stratiﬁed by latency periods following the initial NHL diagnosis.  \nResults: The cohort included 54 012 NHL patients. The authors’ results showed that for most SPCs, the risk of development was different for different primary NHL lymph node locations. The highest risks were observed for thyroid cancer, acute myeloid leukemia, and Hodgkin lymphoma. Notably, the risk for thyroid cancer was highest in the ﬁrst year post-diagnosis, while hematological malignancies such as acute myeloid leukemia and Hodgkin lymphoma showed elevated risks in the intermediate and late latency periods.  \nConclusion: NHL survivors are at an increased risk of developing SPCs, inﬂuenced by the primary lymph node site and latency period. These ﬁndings highlight the need for tailored surveillance strategies and preventive measures to mitigate the long-term risks of SPCs in NHL survivors. Further research is necessary to elucidate the underlying mechanisms and to develop targeted interventions for this high-risk population.  \nKeywords: non-Hodgkin lymphoma, primary lymph node site, second primary cancer  \nIntroduction  \nNon-Hodgkin lymphoma (NHL) is a diverse group of blood cancers that develop in the lymphatic system. NHL can start in various lymph nodes throughout the body and encompasses a wide variety of subtypes, each with distinct pathological and clinical features. The incidence of NHL has been rising globally, with an estimated 77 240 new cases diagnosed in the United States in 2020 alone[1] . Due to advancements in treatment and  \naFaculty of Medicine, Lebanese University, Hadat, Lebanon, bSchool of Medicine and Medical Sciences, Holy Spirit University ofKaslik, Jounieh, Lebanon and cApplied Science Research Center, Applied Science Private University, Amman, Jordan  \nSponsorships or competing interests that maybe relevant to content are disclosed atthe end of this articles.  \n*Corresponding author. Address: Beirut, Lebanon. Tel.: +96 179 304 527.  \n[E-mail: alihemade3@gmail.com](E-mail: alihemade3@gmail.com) (A. Hemade).  \nCopyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nAnnals of Medicine & Surgery (2024) 86:6455–6464  \nReceived 29 July 2024; Accepted 1 October 2024  \nPublished online 8 October 2024  \n[http://dx.doi.org/10.1097/MS9.0000000000002644](http://dx.doi.org/10.1097/MS9.0000000000002644)  \nHIGHLIGHTS  \n• Non-Hodgkin lymphoma survivors face a markedly higher risk of developing second primary cancers.  \n• The study identiﬁes forthe ﬁrst time that the primary lymph node location signiﬁcantly inﬂuences the risk of speciﬁc SPCs, such as ","cbCaidtfeBfQa5qn","https://ap.wps.com/l/cbCaidtfeBfQa5qn","pdf",1262402,"English","# Introduction\n## Background on non-Hodgkin lymphoma and second primary cancers\n# Methods\n## Data source, cohort definition, and risk metrics\n## Stratification by latency\n# Results\n## Cohort size and site-specific risk patterns\n## Latency-specific findings\n# Conclusion\n## Clinical implications and need for further research","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To determine how the primary lymph node location and the latency period after nodal non-Hodgkin lymphoma diagnosis influence the risk of second primary cancers.\"},{\"question\":\"How was the study conducted?\",\"answer\":\"It used a retrospective population-based cohort design with Surveillance, Epidemiology, and End Results data from 2000 to 2021, including nodal NHL patients as first primary cancers.\"},{\"question\":\"Which second primary cancers showed the highest risks?\",\"answer\":\"The highest risks were reported for thyroid cancer, acute myeloid leukemia, and Hodgkin lymphoma.\"},{\"question\":\"Why do the results matter for patient care?\",\"answer\":\"The risk varies by lymph node site and latency, supporting the need for tailored surveillance strategies and preventive measures, along with further research into underlying mechanisms.\"}]","Risk of second primary cancers in nodal non-Hodgkin lymphoma patients by primary lymph node location - Cohort study | PDF",1790045127,25,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cefced8fe08f43e36f59ac1595845c01.webp",983,1310,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8f71a5e426c7900638aa581f8b2a896.webp",982,1309,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0cb72aaa943042262789b9dd31ac53c.webp",981,1308,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7733a510320382fa20230a4f207f7f4.webp",980,734]